secwatch.observer — SEC 8-K summary
======================================

Issuer:     MEDIFAST INC (MED)
CIK:        0000910329
Form:       8-K
Filed at:   2022-11-03T23:59:59+00:00
Accession:  0001628280-22-028179
Event type: earnings
Sentiment:  negative
Materiality: 0.85
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Medifast Q3 revenue down 5.6%; cuts FY2022 revenue and EPS guidance on macro headwinds
--------------------------------------------------------------------------------

- Revenue $390.4M (-5.6% YoY); net income $36.2M ($3.27 diluted EPS). Non-GAAP adjusted EPS $3.32.
- Active earning OPTA VIA Coaches 66,200 (+8.5% YoY) but revenue per coach fell 12.9% to $5,897.
- Full-year 2022 revenue guidance cut to $1.51B-$1.59B from $1.58B-$1.66B; non-GAAP EPS to $11.61-$13.05 from $12.70-$14.10.
- Gross margin 72.5% vs 74.3% prior year; cash $69.7M, zero debt; completed $100M ASR program.
- Quarterly dividend of $1.64 per share declared; Euromonitor ranked OPTA VIA #1 U.S. weight loss program by revenue.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/910329/000162828022028179/0001628280-22-028179-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/910329/000162828022028179/med-20221103form8xk.htm
  HTML page:      https://secwatch.observer/filing/0001628280-22-028179

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer